Dechra
This coverage focuses on Dechra, a global veterinary pharmaceuticals company with a strong footprint in the UK petcare and animal health market. Pet Gazette reports on Dechra’s product innovations, acquisitions, and distribution strategies, as well as its role in supporting veterinary practices and supply chain partners. Coverage includes news, business analysis, and case studies that explore how Dechra’s developments impact retailers, wholesalers, and supply specialists, while also shaping wider trends in animal health and welfare.
-
Jul- 2024 -22 JulyVeterinary
Dechra Pharmaceuticals to acquire Invetx
UK-based provider of veterinary pharmaceuticals Dechra has announced its plans to acquire Invetx, a Boston, MA-based company which specialises in protein-based therapeutics for animal health, for up to $520m (£402.76m). According to Invetx, the acquisition remains subject to antitrust approval and other customary closing conditions. In addition to the Invetx…
Read More » -
Jun- 2023 -2 JuneRetailers
Dechra Pharmaceuticals agrees to £4.5bn takeover deal
Veterinary pharma company Dechra Pharmaceuticals has agreed a £4.5bn takeover deal from Swedish private equity firm EQT. The veterinary pharmaceutical company said it reached an agreement with Freya Bidco Ltd, a newly formed company indirectly owned by EQT X EUR SCSp and EQT X USD SCSp, which act through its…
Read More » -
May- 2023 -5 MayRetailers
Dechra takes on distribution of feline kidney supplements
Dechra has taken on the distribution of Porus One and Add One supplements that support long-term kidney health in cats. Porus One contains renaltec, a selective absorber that soaks up precursors of uraemia toxins in the cat’s intestines that would “ordinarily be removed or regulated by healthy kidneys”. It contains…
Read More » -
Nov- 2020 -27 NovemberIndustry News
Dechra Veterinary Products launches new sustainable packaging
Dechra Veterinary Products has launched fully recyclable packaging for its new organic range of ‘Specific pet food’ as the company continues its ‘Circle of Good’ commitment to provide more ethical choices for pet owners. According to the business, the new packaging features single layers of the same recyclable plastic with…
Read More » -
Aug- 2020 -6 AugustVeterinary
Dechra extends dermatology range with Osurnia
Veterinary pharmaceuticals firm Dechra has announced the expansion of its range of products to treat otitis externa with the introduction of Osurnia. The announcement follows Dechra’s acquisition of the worldwide rights to the marketing and manufacture of the product from Elanco Animal Health Inc. Osurnia is formulated for the treatment…
Read More »
